Canada Cell Sorting Market

Canada Cell Sorting Market Size Insights Forecasts to 2035

• The Canada Cell Sorting Market Size was estimated at USD 60.33 Million in 2024
• The Market Size is Expected to Grow at a CAGR of around 8.31% from 2025 to 2035
• The Canada Cell Sorting Market Size is Expected to Reach USD 145.22 Million by 2035

According to a Research Report Published by Decisions Advisors and Consulting, The Canada Cell Sorting Market Size is anticipated to Reach USD 145.22 Million by 2035, Growing at a CAGR of 8.31% from 2025 to 2035. The market growth is driven by ongoing technological advancements like automation, software-enabled workflows, and microfluidics. Major players in companies in the market collaborate with hospitals, research facilities, medical schools, and pharmaceutical companies, which boost the market development. The Canadian cell sorting market is well-positioned for continued innovation and growth as funding for life sciences and healthcare R&D keeps increasing.

Market Overview

The Canada cell sorting market refers to the industry focused on the biotechnology and life sciences sector in Canada that focuses on products and services that separate and categorise cells according to particular traits, mostly for use in research, diagnostics, and treatment. Advances in technology have led to a significant growth in the cell sorting market. Automation, software integration, and improvements in instrument sensitivity have further increased the reliability of sorting results, making these technologies available in a wider range of clinical and laboratory settings. As a result, adoption rates for research and therapeutic applications have gone up, which has spurred market growth. The global cell sorting market is growing at a significant rate due to the growing demand for sophisticated cell-based assays in immunology, oncology, and stem cell research, as well as the growing emphasis on single-cell analysis and precision medicine. The Canadian government commemorated the grand opening of Tailored Genes' new biotech facility in Concord, Ontario. This represents a calculated investment in health innovation and the production of viral vectors. More than $1 million through FedDev Ontario for cutting-edge equipment to improve gene and cell therapy testing and development at the new facility, to treat rare and serious illnesses. The company is moving from Toronto Western Hospital to a larger, more modern facility as part of a project worth over $2 million.

Report Coverage

This research report categorises the market for the Canada cell sorting market based on various segments and regions, and forecasts revenue growth and analyses trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the Canada cell sorting market. Recent market developments and competitive strategies, such as expansion, product launch, development, partnership, merger, and acquisition, have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub-segment of the Canada cell sorting market.

Driving Factors

The market for Canada cell sorting is primarily driven by the rising incidence of chronic illnesses like cancer, autoimmune diseases, and cardiovascular diseases is a major driver. The application of high-precision cell sorting devices is fueled by the growing need for individualised and targeted therapies, such as immunotherapies and stem cell treatments. Further, growing research funding and strategic alliances are opening up a lot of market expansion prospects. Moreover, to further biomedical science, governments and private organisations are making significant investments in initiatives that use cell sorting.

Restraining Factors

A major challenge is the high initial capital investment required to purchase advanced cell sorting instruments, which can be prohibitively expensive for smaller academic labs, emerging biotechnology firms, and healthcare institutions with limited budgets. Further, ongoing operational costs and the technical complexity of cell sorting systems with strict regulatory requirements hampered the market.

Market Segmentation

The Canada Cell Sorting market share is classified into product type and technology.

• The reagents & consumables segment held a significant share in 2024 and is anticipated to grow at a rapid pace over the forecast period.

The Canada cell sorting market is divided by product type into reagents & consumables, cell sorters, and services. Among these, the reagents & consumables segment held a significant share in 2024 and is anticipated to grow at a rapid pace over the forecast period. This is due to the rising demand for buffer solutions, staining dyes, and antibodies is expected to be driven by research labs. Moreover, the segment growth is expanded due to increased research funding, with the adoption of antibodies for experiments with high reproducibility.

• The fluorescence-based droplet cell sorting segment dominated the market in 2024 and is projected to grow at a significant CAGR during the forecast period.

The Canada cell sorting market is segmented by technology into fluorescence-based droplet cell sorting (jet-in-air cell sorting, cuvette-based cell sorting), MEMS - microfluidics, and magnetic-activated cell sorting. Among these, the fluorescence-based droplet cell sorting segment dominated the market in 2024 and is projected to grow at a significant CAGR during the forecast period. This is because of its multi-parameter analysis capabilities and high precision. Further, droplet-based systems for single-cell research are expected to be adopted by labs to increase the sensitivity of detection. For instance, immunology research, academic and commercial labs are probably going to prefer this technology.

Competitive Analysis:

The report offers the appropriate analysis of the key organisations/companies involved within the Canada cell sorting market, along with a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.

List of Key Companies

• STEMCELL Technologies
• Precision NanoSystems
• Toronto Biotech Inc.
• Northern RNA
• Zymeworks Inc
• Notch Therapeutics
• AvroBio Inc
• Others

Recent Developments:

• In October 2025, the University of Saskatchewan (USask) launched a cutting-edge cell sorting hub, backed by over $460,000 in national funding, to accelerate medical and veterinary research. With the help of this new cell sorter, scientists will be able to isolate particular cell types from samples in order to investigate specific cell functions, such as the effects of disease on various cell types.

Key Target Audience

• Market Players
• Investors
• End-users
• Government Authorities 
• Consulting and Research Firm
• Venture capitalists
• Value-Added Resellers (VARs)

Market Segment

This study forecasts revenue at Canada, regional, and country levels from 2020 to 2035. Decisions Advisors has segmented the Canada Cell Sorting Market based on the below-mentioned segments:

Canada Cell Sorting Market, By Product Type

• Reagents & Consumables
• Cell Sorters
• Services

Canada Cell Sorting Market, By Technology

• Fluorescence-based Droplet Cell Sorting (Jet-in-air Cell Sorting, and Cuvette-based Cell Sorting)
• MEMS – Microfluidics
• Magnetic-activated Cell Sorting